Menu
 
Research menu
Jump to menu

Publications:  Dr Ruth Dobson

Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J et al.(2020). Protecting people with multiple sclerosis through vaccination. Pract Neurol
10.1136/practneurol-2020-002527
Kuri A, Jacobs BM, Vickaryous N, Pakpoor J, Middeldorp J, Giovannoni G, Dobson R(2020). Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. BMC Public Health vol. 20, (1)
10.1186/s12889-020-09049-x
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65285
Dobson R, Jokubaitis V, Giovannoni G(2020). Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis. Multiple Sclerosis and Related Disorders
10.1016/j.msard.2020.102241
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64764
Taylor TR, Jacobs BM, Giovannoni G, Petrushkin H, Dobson R(2020). Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study. Mult Scler Relat Disord vol. 43,
10.1016/j.msard.2020.102209
Dobson R, Mowry EM(2020). Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis. Neurology vol. 94, (18) 769-770.
10.1212/WNL.0000000000009369
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65298
Leddy S, Jacobs BM, Giovannoni G, Dobson R (2020). To examine the impact of Multiple Sclerosis on bone health and explore mechanisms for this association. EUROPEAN JOURNAL OF NEUROLOGY. vol. 27, 981-981.
Dobson R, Jitlal M, Marshall CR, Noyce AJ, Robson J, Cuzick J, Giovannoni G(2020). Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk. Annals of Neurology vol. 87, (4) 599-608.
10.1002/ana.25688
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62858
Dobson R, Jacobs B, Giovannoni G, Cuzick J(2020). Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors. Multiple Sclerosis Journal
10.1177/1352458520907901
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63739
Jokubaitis V, Dobson R(2020). Family planning is the second most relevant factor for treatment decisions after disease activity. Multiple Sclerosis Journal
10.1177/1352458520907902
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63008
Dobson R, Noyce A, Giovannoni G, jacobs B(2020). BMI and low serum vitamin D are causal risk factors for Multiple Sclerosis: a Mendelian Randomisation study. Neurology, Neuroimmunology and Neuroinflammation
10.1212/NXI.0000000000000662
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62737
Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R et al.(2020). Sex effects across the lifespan in women with multiple sclerosis. Therapeutic Advances in Neurological Disorders vol. 13,
10.1177/1756286420936166
Dobson R, Jitlal M, Marshall C, Noyce A, Giovannoni G (2019). Obesity is not associated with MS in a socially and ethnically diverse population. MULTIPLE SCLEROSIS JOURNAL. vol. 25, 49-49.
Vickaryous N, Jitlal M, Middleton R, Giovannoni G, Dobson R (2019). Vitamin D levels in the UK MS population. MULTIPLE SCLEROSIS JOURNAL. vol. 25, 449-450.
DOBSON R(2019). Visibility and representation of women in multiple sclerosis research. Neurology
10.1212/WNL.0000000000007276
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56468
Dobson R, Dassan P, Roberts M, Giovannoni G, Nelson-Piercy C, Brex PA(2019). UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines. Pract Neurol
10.1136/practneurol-2018-002060
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54858
Dobson R(2018). Clinical commentary on 'Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: a note of caution'. Mult Scler1352458518807053-1352458518807053.
10.1177/1352458518807053
https://qmro.qmul.ac.uk/xmlui/handle/123456789/51423
Dobson R, Giovannoni G(2018). Multiple Sclerosis - a review. Eur J Neurol vol. 26, 27-40.
10.1111/ene.13819
https://qmro.qmul.ac.uk/xmlui/handle/123456789/48023
Thomson A, Aldam R, Giovannoni G, Dobson R (2018). Making science digestible: the development of educational activities for children with a parent with MS, and the need to better engage families. MULTIPLE SCLEROSIS JOURNAL. vol. 24, 972-972.
Dobson R, Cock HR, Brex P, Giovannoni G(2018). Vitamin D supplementation. Pract Neurol vol. 18, (1) 35-42.
10.1136/practneurol-2017-001720
https://qmro.qmul.ac.uk/xmlui/handle/123456789/51003
Middleton RM, Rodgers WJ, Giovannoni G, Schmierer K, Dobson R, Allen-Philbey K, Patterson A, Akbari A et al. (2017). A Comparison of participant supplied EDSS scores and clinically submitted data via the UK MS Register. MULTIPLE SCLEROSIS JOURNAL. vol. 23, 153-154.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64994
Dobson R, Kuhle J, Middeldorp J, Giovannoni G(2017). Epstein-Barr-negative MS: a true phenomenon?. Neurol Neuroimmunol Neuroinflamm vol. 4, (2) e318-e318.
10.1212/NXI.0000000000000318
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34427
Dobson R, Ramagopalan S, Topping J, Smith P, Solanky B, Schmierer K, Chard D, Giovannoni G(2016). A Risk Score for Predicting Multiple Sclerosis. PLoS One vol. 11, (11) Article 0164992, e0164992-e0164992.
10.1371/journal.pone.0164992
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18832
Collins CDE, Ivry B, Bowen JD, Cheng EM, Dobson R, Goodin DS, Lechner-Scott J, Kappos L et al.(2016). A comparative analysis of Patient-Reported Expanded Disability Status Scale tools. Mult Scler vol. 22, (10) 1349-1358.
10.1177/1352458515616205
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54862
Binks S, Dobson R(2016). Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease. Curr Osteoporos Rep vol. 14, (5) 199-210.
10.1007/s11914-016-0320-5
Topping J, Dobson R, Lapin S, Maslyanskiy A, Kropshofer H, Leppert D, Giovannoni G, Evdoshenko E(2016). The effects of intrathecal rituximab on biomarkers in multiple sclerosis. Mult Scler Relat Disord vol. 6, 49-53.
10.1016/j.msard.2016.01.001
Davis AG, Dobson R, Kaninia S, Giovannoni G, Schmierer K(2016). Atraumatic needles for lumbar puncture: Why haven’t neurologists changed?. Practical Neurology vol. 16, (1) 18-22.
10.1136/practneurol-2014-001055
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10032
Disanto G, Adiutori R, Dobson R, Martinelli V, Costa GD, Runia T, Evdoshenko E, Thouvenot E et al.(2016). Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. Journal of Neurology, Neurosurgery and Psychiatry vol. 87, (2) 126-129.
10.1136/jnnp-2014-309690
Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, Lu C-H, Dobson R et al.(2015). Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. J Neurol Neurosurg Psychiatry vol. 86, (3) 273-279.
10.1136/jnnp-2013-307454
Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC et al.(2015). Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Multiple Sclerosis Journal vol. 21, (8) 1013-1024.
10.1177/1352458514568827
https://qmro.qmul.ac.uk/xmlui/handle/123456789/7011
Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ(2014). Bone health in Parkinson's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry vol. 85, (10) 1159-1166.
10.1136/jnnp-2013-307307
https://qmro.qmul.ac.uk/xmlui/handle/123456789/37224
Leddy S, Fowler AJ, Giovanonni G, Dobson R (2014). DEPRESSION IN MS: A SYSTEMATIC REVIEW AND META-ANALYSIS. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 85,
10.1136/jnnp-2014-309236.134
Cooper R, Doshi A, Harris P, Sivagnanasundaram J, Wells G, Barritt A, Aram J, Giovannoni G et al. (2014). IMMUNOCOMPETENT PML-AN IMMUNOLOGICAL SCOTOMA?. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 85,
10.1136/jnnp-2014-309236.112
Disanto G, Dobson R, Pakpoor J, Elangovan RI, Adiutori R, Gobbi C, Kuhle J, Giovannoni G (2014). Genetic predictors of multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL. vol. 20, 253-253.
Shribman S, Torsney KM, Noyce AJ, Giovannoni G, Fearnley J, Dobson R(2014). A service development study of the assessment and management of fracture risk in Parkinson's disease. J Neurol vol. 261, (6) 1153-1159.
10.1007/s00415-014-7333-8
https://qmro.qmul.ac.uk/xmlui/handle/123456789/42544
Disanto G, Dobson R, Pakpoor J, Elangovan RI, Adiutori R, Kuhle J, Giovannoni G(2014). The refinement of genetic predictors of multiple sclerosis. PLoS ONE vol. 9, (5)
10.1371/journal.pone.0096578
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54861
Shribman SE, Torsney K, Noyce AJ, Giovannoni G, Fearnley J, Dobson R (2014). A service development study of the assessment and management of fracture risk in Parkinson's disease. MOVEMENT DISORDERS. vol. 29, S192-S192.
Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ (2014). A systematic review and meta-analysis of fracture risk in Parkinson's disease. MOVEMENT DISORDERS. vol. 29, S551-S551.
Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ (2014). Bone health in Parkinson's disease: A systematic review and meta-analysis. MOVEMENT DISORDERS. vol. 29, S551-S551.
Raffel J, Dobson R, Gafson A, Mattoscio M, Muraro P, Giovannoni G(2014). Multiple sclerosis therapy and Epstein-Barr virus antibody titres. Mult Scler Relat Disord vol. 3, (3) 372-374.
10.1016/j.msard.2013.12.004
Davis A, Dobson R, Kaninia S, Espasandin M, Berg A, Giovannoni G, Schmierer K(2014). Change practice now! Using atraumatic needles to prevent post lumbar puncture headache. European Journal of Neurology vol. 21, (2) 305-311.
10.1111/ene.12307
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12000
Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G(2014). Assessing treatment response to interferon-beta Is there a role for MRI?. NEUROLOGY vol. 82, (3) 248-254.
10.1212/WNL.0000000000000036
https://qmro.qmul.ac.uk/xmlui/handle/123456789/43428
Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G(2014). Assessing treatment response to interferon-β :Is there a role for MRI?. Neurology vol. 82, (3) 248-254.
10.1212/WNL.0000000000000036
Hadavi S, Baker MD, Dobson R(2014). Sustained-release fampridine in Multiple Sclerosis. Mult Scler Relat Disord vol. 3, (1) 17-21.
10.1016/j.msard.2013.06.003
Leddy S, Hadavi S, Carren AM, Giovanonni G, Dobson R(2013). A novel internet-based method of capturing outcomes in multiple sclerosis. J Neurol Neurosurg Psychiatry vol. 84, (11)
10.1136/jnnp-2013-306573.9
Hadavi S, Giovannoni G, Dobson R(2013). A service development audit of fampridine use in ms. J Neurol Neurosurg Psychiatry vol. 84, (11)
10.1136/jnnp-2013-306573.178
Hadavi S, Shribman S, Nagy A, Acharya S, Fearnley J, Dobson R, Lees A, Giovannoni G et al.(2013). The bradykinesia-akinesia incoordination test: a simple objective test in multiple sclerosis. J Neurol Neurosurg Psychiatry vol. 84, (11)
10.1136/jnnp-2013-306573.184
Dobson R, McMillan A, Kung K, Thom M, Davis A, Simister R, Giovannoni G, Gnanapavan S(2013). Think outside the box, collapse the box, and take a sharp knife to it!. J Neurol Neurosurg Psychiatry vol. 84, (11)
10.1136/jnnp-2013-306573.173
Dobson R, Topping J, Ramagopalan S, Giovannoni G(2013). Towards an endophenotype in multiple sclerosis. J Neurol Neurosurg Psychiatry vol. 84, (11)
10.1136/jnnp-2013-306573.31
Leddy S, Hadavi S, McCarren A, Giovannoni G, Dobson R (2013). A novel internet-based method of capturing outcomes in multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL. vol. 19, 357-358.
Kuhle J, Dobson R, Bestwick JP, Topping J, Dalla Costa G, Khademi M, Sombekke M, Killestein J et al. (2013). Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS. MULTIPLE SCLEROSIS JOURNAL. vol. 19, 33-34.
James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV(2013). The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis. Mult Scler vol. 19, (12) 1571-1579.
10.1177/1352458513489756
Leddy S, Hadavi S, McCarren A, Giovannoni G, Dobson R(2013). Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis. J Neurol vol. 260, (10) 2505-2510.
10.1007/s00415-013-7004-1
Dobson R, Ramagopalan S, Davis A, Giovannoni G(2013). Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry vol. 84, (8) 909-914.
10.1136/jnnp-2012-304695
Dobson R, Giovannoni G(2013). Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis. J Neurol vol. 260, (5) 1272-1285.
10.1007/s00415-012-6790-1
Dobson R, Yarnall A, Noyce AJ, Giovannoni G(2013). Bone health in chronic neurological diseases: a focus on Multiple sclerosis and Parkinsonian syndromes. Pract Neurol vol. 13, (2) 70-79.
10.1136/practneurol-2012-000435
Dobson R, Giovannoni G, Ramagopalan S(2013). The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J Neurol Neurosurg Psychiatry vol. 84, (4) 427-432.
10.1136/jnnp-2012-303934
Dobson R, Leddy SG, Gangadharan S, Giovannoni G(2013). Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems. BMJ Open vol. 3, (3)
10.1136/bmjopen-2012-002508
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54863
Dobson R, Ramagopalan SV, Giovannoni G(2013). Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?. Expert Rev Neurother vol. 13, (3) 235-237.
10.1586/ern.13.13
Pakpoor J, Disanto G, Gerber JE, Dobson R, Meier UC, Giovannoni G, Ramagopalan SV(2013). The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Mult Scler vol. 19, (2) 162-166.
10.1177/1352458512449682
Dobson R, Ramagopalan S, Davis A, Giovannoni G(2013). Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis of prevalence, prognosis and effect of latitude. Journal of Neurology, Neurosurgery and Psychiatry vol. 84, (8) 909-914.
10.1136/jnnp-2012-304695
Dobson R, Topping J, Giovannoni G(2013). Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers. J Med Virol vol. 85, (1) 128-131.
10.1002/jmv.23446
Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV(2013). Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine. PLoS One vol. 8, (4)
10.1371/annotation/274e5ef1-79aa-48f7-af62-0594d5c1354e
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5223
Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU et al.(2013). Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One vol. 8, (9)
10.1371/journal.pone.0075091
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54859
Dobson R, Giovannoni G, Ramagopalan S(2013). The month of birth effect in multiple sclerosis: Systematic review, meta-analysis and effect of latitude. Journal of Neurology, Neurosurgery and Psychiatry vol. 84, (4) 427-432.
10.1136/jnnp-2012-303934
Dobson R, Ramagopalan S, Giovannoni G(2012). Bone health and multiple sclerosis. Mult Scler vol. 18, (11) 1522-1528.
10.1177/1352458512453362
Dobson R, Rudick RA, Giovannoni G (2012). CAN WE RELIABLY USE MRI TO MONITOR TREATMENT RESPONSE IN PATIENTS ON INTERFERON beta: A SYSTEMATIC REVIEW AND META-ANALYSIS. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 83,
10.1136/jnnp-2012-304200a.127
Dobson R, Ramagopalan S, Giovannoni G(2012). Risk of fractures in patients with multiple sclerosis: A populationbased cohort study. Neurology vol. 79, (18) 1934-1935.
10.1212/01.wnl.0000422676.74031.07
Davis A, Dobson R, Espasandin M, Giovannoni G, Schmierer K (2012). Cerebrospinal fluid biomarkers as outcome measures in clinical trials of MS: The significance of post lumbar puncture headaches. MULTIPLE SCLEROSIS JOURNAL. vol. 18, 237-238.
Dobson R, Ramagopalan S, Giovannoni G (2012). Osteoporosis and fracture risk in multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL. vol. 18, 243-244.
Topping J, Evdoshenko E, Dobson R, Lapin S, Maslyanskiy A, Giovannoni G (2012). The effects of intrathecal rituximab on biomarkers in MS. MULTIPLE SCLEROSIS JOURNAL. vol. 18, 268-268.
Dobson R, Topping J, Davis A, Giovannoni G (2012). Urinary and CSF biomarkers in multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL. vol. 18, 502-503.
Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV(2012). Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine. PLoS ONE vol. 7, (9)
10.1371/journal.pone.0045295
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54864
Dobson R, Ramagopalan S, Giovannoni G(2012). The effect of gender in clinically isolated syndrome (CIS): a meta-analysis. Mult Scler vol. 18, (5) 600-604.
10.1177/1352458511426740
Dobson R(2012). Urine: An under-studied source of biomarkers in multiple sclerosis?. Mult Scler Relat Disord vol. 1, (2) 76-80.
10.1016/j.msard.2012.01.002
Disanto G, Sandve GK, Berlanga-Taylor AJ, Morahan JM, Dobson R, Giovannoni G, Ramagopalan SV(2012). Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells. PLOS ONE vol. 7, (3) Article ARTN e32281,
10.1371/journal.pone.0032281
https://qmro.qmul.ac.uk/xmlui/handle/123456789/4924
Dobson R, Meier UC, Schmierer K, Giovannoni G (2012). DO SIBLINGS OF PEOPLE WITH MULTIPLE SCLEROSIS (MS) HAVE MARKERS OF MS RISK?. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 83,
10.1136/jnnp-2011-301993.173
https://qmro.qmul.ac.uk/xmlui/handle/123456789/7015
Raffel J, Dobson R, Giovannoni G (2012). THE EFFECT OF NATALIZUMAB AND INTERFERON-beta ON URINARY FREE LIGHT CHAINS AND ANTI-EBV NUCLEAR ANTIGEN-1 ANTIBODIES IN RELAPSING REMITTING MULTIPLE SCLEROSIS. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 83,
10.1136/jnnp-2011-301993.190
Dobson R, Giovannoni G (2012). WHY CAN'T I WIN ANY MORE?. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 83,
10.1136/jnnp-2011-301993.200
Dobson R, Meier UC, Marta M, Ramagopalan S, Giovannoni G(2011). Vitamin D deficiency - do we follow our own advice?. CLINICAL MEDICINE vol. 11, (6) 521-523.
10.7861/clinmedicine.11-6-521
Dobson R, Meier UC, Schmierer K, Giovannoni G(2011). Do siblings have markers of multiple sclerosis risk?. MULTIPLE SCLEROSIS JOURNAL vol. 17, S86-S86.
Dobson R, Lawden M(2011). Melanoma associated retinopathy and how to understand the electroretinogram. Pract Neurol vol. 11, (4) 234-239.
10.1136/practneurol-2011-000061
Maghzi A-H, Marta M, Bosca I, Etemadifar M, Dobson R, Maggiore C, Giovannoni G, Meier U-C(2011). Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?. Pathophysiology vol. 18, (1) 13-20.
10.1016/j.pathophys.2010.04.003
Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV(2011). Smoking and Multiple Sclerosis: An Updated Meta-Analysis. PLOS ONE vol. 6, (1) Article e16149,
10.1371/journal.pone.0016149
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5463
Meier UC, Giovannoni G(2011). More to come: humoral immune responses in MS. Journal of Neuroimmunology vol. 240-241, 13-21.
10.1016/j.jneuroim.2011.09.009
Dobson R, Feldmann M, Thompson AJ, Giovannoni G, Miller DH, Thompson EJ, Palmer HE, Miller RF (2010). INCREASED URINARY FREE IMMUNOGLOBULIN LIGHT CHAIN EXCRETION IN PATIENTS WITH MULTIPLE SCLEROSIS. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 81, E57-E57.
10.1136/jnnp.2010.226340.159
Ramagopalan SV, Dobson R, Meier UC, Giovannoni G(2010). Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol vol. 9, (7) 727-739.
10.1016/S1474-4422(10)70094-6
Dobson R, Miller RF, Palmer HE, Feldmann M, Thompson EJ, Thompson AJ, Miller DH, Giovannoni G(2010). Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis. J Neuroimmunol vol. 220, (1-2) 99-103.
10.1016/j.jneuroim.2010.01.012
Return to top